Mandatory notification of trade

Oslo, 04.10.2011 - CEO of Bionor Pharma ASA, Steen Krøyer, has today purchased 100,000 shares

CEO of Bionor Pharma ASA, Steen Krøyer, has today purchased 100,000 BIONOR shares at an average of NOK 1.20 per share. The shares are held through a nominee account in Nordea Luxembourg.

Steen Krøyer's holding after the purchase is 100,000 BIONOR shares.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.